English
 
Help Privacy Policy Disclaimer
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT
  AATF/Che-1 acts as a phosphorylation-dependent molecular modulator to repress p53-driven apoptosis

Höpker, K., Hagmann, H., Khurshid, S., Chen, S., Hasskamp, P., Seeger-Nukpezah, T., et al. (2012). AATF/Che-1 acts as a phosphorylation-dependent molecular modulator to repress p53-driven apoptosis. EMBO Journal, 31(20), 3961-3975. doi:10.1038/emboj.2012.236.

Item is

Files

show Files

Locators

show

Creators

show
hide
 Creators:
Höpker, Katja1, Author
Hagmann, Henning1, Author
Khurshid, Safiya1, Author
Chen, Shuhua2, Author           
Hasskamp, Pia1, Author
Seeger-Nukpezah, Tamina1, Author
Schilberg, Katharina1, Author
Heukamp, Lukas1, Author
Lamkemeyer, Tobias1, Author
Sos, Martin L.2, Author           
Thomas, Roman K.2, Author           
Lowery, Drew1, Author
Roels, Frederik1, Author
Fischer, Matthias1, Author
Liebau, Max C.1, Author
Resch, Ulrike1, Author
Kisner, Tülay1, Author
Röther, Fabian1, Author
Bartram, Malte P.1, Author
Müller, Roman Ulrich1, Author
Fabretti, Francesca1, AuthorKurschat, Peter1, AuthorSchumacher, Björn1, AuthorGaestel, Matthias1, AuthorMedema, Rene H.1, AuthorYaffe, Michael B.1, AuthorSchermer, Bernhard1, AuthorReinhard, H. Christian1, AuthorBenzing, Thomas1, Author more..
Affiliations:
1a Department II of Internal Medicine, University Hospital of Cologne, Cologne, Germany b 1] Department II of Internal Medicine, University Hospital of Cologne, Cologne, Germany c Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, Cologne, Germany d 1] Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, Cologne, Germany e Department I of Internal Medicine, University Hospital of Cologne, Cologne, Germany f Institute of Pathology, University of Cologne, Cologne, Germany g 1] Max Planck Institute for Neurological Research with Klaus-Joachim-Züls-Laboratories of the Max Planck Society and the Medical Faculty of the University of Cologne, Cologne, Germany h Department of Translational Genomics, University of Cologne, Cologne, Germany i Howard Hughes Medical Institute, Department of Cellular and Molecular Pharmacology, University of California, San Francisco, CA, USA j 1] Institute of Pathology, University of Cologne, Cologne, Germany k Massachusetts Institute of Technology, Koch Institute for Integrative Cancer Research, Cambridge, MA, USA l Department of Pediatrics, University Hospital of Cologne, Cologne, Germany m 1] Department of Pediatrics, University Hospital of Cologne, Cologne, Germany n Center for Molecular Medicine Cologne, University of Cologne, Cologne, Germany o Department of Dermatology, University Hospital of Cologne, Cologne, Germany p Systems Biology of Aging, University of Cologne, Cologne, Germany q Institute of Physiological Chemistry, Hannover Medical University, Hannover, Germany r Division of Cell Biology, The Netherlands Cancer Institute, Amsterdam, The Netherlands, ou_persistent22              
2Funktionelle Krebsgenomforschung, Junior Research Groups, Max-Planck-Institut für neurologische Forschung, Managing Director: D. Yves von Cramon, Max Planck Institute for Metabolism Research, Managing Director: Jens Brüning, Max Planck Society, ou_2149656              

Content

show

Details

show
hide
Language(s): eng - English
 Dates: 2012
 Publication Status: Published in print
 Pages: -
 Publishing info: -
 Table of Contents: -
 Rev. Type: Peer
 Identifiers: eDoc: 614877
DOI: 10.1038/emboj.2012.236
 Degree: -

Event

show

Legal Case

show

Project information

show

Source 1

show
hide
Title: EMBO Journal
Source Genre: Journal
 Creator(s):
Affiliations:
Publ. Info: -
Pages: - Volume / Issue: 31 (20) Sequence Number: - Start / End Page: 3961 - 3975 Identifier: ISSN: 02614189